Dual Inhibition of CDK4/6 and mTORC1 Establishes a Preclinical Strategy for Translocation Renal Cell Carcinoma.
CDK4/6 和 mTORC1 的双重抑制为易位性肾细胞癌建立了一种临床前治疗策略
期刊:
影响因子:
doi:10.1101/2025.07.11.663903
Gupta Shikha, Khanna Prateek, Saad Eddy, Saliby Renee Maria, AbuHammad Shatha, Li Jiao, Li Bingchen, Konda Prathyusha, Ahmed Usman Ali, Sadagopan Ananthan, Xu Qingru, Bakouny Ziad, Xu Wenxin, Srinivasan Ramaprasad, Choueiri Toni K, Viswanathan Srinivas R
